Product

Safety

1 clinical trial

1 indication

Indication
Mesothelioma
Clinical trial
Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Status: Recruiting, Estimated PCD: 2023-08-31